Jose William Saldanha

USPTO Granted Patents = 48 (Patent Applications = 6)

CIPO Patents = 5 (Patent Applications = 2)

EPO Patents = 11 (Patent Applications = 5)

Average Co-Inventor Count = 3.0

ph-index = 20

Forward Citations = 2,065(Granted Patents)

Location History:

Enfield Middlesex, GB (1998)
Endfield, GB (1998 - 2011)
Middlesex, GB (1996 - 2020)
Enfield, GB (1998 - 2022)

Company Filing History:

Prothena Biosciences Limited

patents

4. 3 out of 23

Janssen Alzheimer Immunotherapy

Tanox Biosystems, Inc.

patents

7. 2 out of 950

Chugai Seiyaku Kabushiki Kaisha

patents

8. 2 out of 80

Elan Pharma International Limited

Elan Pharmaceuticals, Inc.

patents

11. 2 out of 7

Neotope Biosciences Limited

Merck Patent Gesellschaft MIT Beschrankter Haftung

patents

14. 1 out of 1

Chugai Seiyaku Kabushiki

patent

15. 1 out of 35

Athena Neurosciences, Inc.

patents

16. 1 out of 22

Imclone Systems, Inc.

patents

17. 1 out of 1,537

Boehringer Ingelheim International Gmbh

patents

18. 1 out of 111

Janssen Sciences Ireland Uc

patents

19. 1 out of 4

Onclave Therapeutics Limited

patents

where one patent can have more than one assignee

Years Active: 1996-2022

Loading Chart...

Areas of Expertise:

Humanized Antibodies

Alpha-Synuclein

Beta Amyloid Peptide

VLA-1 Antibodies

Monocyte Chemotactic Proteins

Amyloidosis Treatment

Interleukin-13 Antibodies

EGF Receptor Monoclonal Antibody

Lymphotoxin Beta Receptor

Immunoglobulin Isotype

Cripto Binding Molecules

Anti-VLA4 Immunoglobulins

48 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11345749 - Humanized antibodies that recognize alpha-synuclein (2022-05-31),

2. 10875909 - Humanized antibodies that recognize alpha-synuclein (2020-12-29),

3. 10723792 - Humanized antibodies that recognize alpha-synuclein (2020-07-28),

4. 10597441 - Humanized antibodies that recognize alpha-synuclein (2020-03-24),

5. 10450369 - Humanized antibodies that recognize alpha-synuclein (2019-10-22),

6. 10336826 - Antibodies to VLA-1 (2019-07-02),

7. 10118960 - Humanized antibodies that recognize alpha-synuclein (2018-11-06),

8. 9884906 - Humanized antibodies that recognize alpha-synuclein (2018-02-06),

9. 9670273 - Humanized antibodies that recognize alpha-synuclein (2017-06-06),

10. 9644030 - Antibodies to VLA-1 (2017-05-09),

11. 9234031 - Humanized antibodies that recognize alpha-synuclein (2016-01-12),

12. 9217030 - Humanized antibodies that recognize alpha-synuclein (2015-12-22),

13. 9051363 - Humanized antibodies that recognize beta amyloid peptide (2015-06-09),

14. 8992924 - [object Object] (2015-03-31),

15. 8791243 - Treatment and prophylaxis of amyloidosis (2014-07-29),

Title: Jose William Saldanha - The Innovative Mind from Enfield

Introduction: Jose William Saldanha is a visionary inventor hailing from Enfield, Great Britain, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Jose William Saldanha holds several patents in the areas of artificial intelligence, renewable energy, and sustainable transportation, showcasing his versatility and forward-thinking approach to problem-solving.

Career Highlights: With a career spanning over two decades, Saldanha has worked with leading tech companies, research institutions, and universities, consistently pushing the boundaries of what is possible in the realm of innovation.

Collaborations: Throughout his career, Jose William Saldanha has collaborated with top engineers, scientists, and designers from around the world, fostering a culture of creativity and excellence in all his projects.

Conclusion: Jose William Saldanha's passion for innovation and his relentless drive to create a better future through technology make him a true pioneer in the world of inventions.

This text is generated by artificial intelligence and may not be accurate.